CETIRIZINE HYDROCHLORIDE ALLERGY Drug Patent Profile
When do Cetirizine Hydrochloride Allergy patents expire, and what generic alternatives are available?
Cetirizine Hydrochloride Allergy is a drug marketed by Apotex, Aurobindo Pharma Ltd, Bionpharma, Catalent, Onesource, Sun Pharm Inds Inc, Perrigo R And D, Aiping Pharm Inc, Amneal Pharms Ny, Apotex Inc, Cipla Ltd, Contract Pharmacal, Dr Reddys Labs Ltd, Glenmark Pharms, Granules, Heritage Pharma, Mylan, Orbion Pharms, Pharmazone, Pld Acquisitions, Sun Pharm Inds Ltd, Taro, Torrent Pharms Llc, Unichem, and Unique. and is included in twenty-eight NDAs.
The generic ingredient in CETIRIZINE HYDROCHLORIDE ALLERGY is cetirizine hydrochloride. There is one drug master file entry for this compound. One hundred and sixty-two suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cetirizine Hydrochloride Allergy
A generic version of CETIRIZINE HYDROCHLORIDE ALLERGY was approved as cetirizine hydrochloride by PADAGIS US on June 17th, 2008.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CETIRIZINE HYDROCHLORIDE ALLERGY?
- What are the global sales for CETIRIZINE HYDROCHLORIDE ALLERGY?
- What is Average Wholesale Price for CETIRIZINE HYDROCHLORIDE ALLERGY?
Summary for CETIRIZINE HYDROCHLORIDE ALLERGY
| US Patents: | 0 |
| Applicants: | 25 |
| NDAs: | 28 |
| Finished Product Suppliers / Packagers: | 134 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 95 |
| Patent Applications: | 4,703 |
| DailyMed Link: | CETIRIZINE HYDROCHLORIDE ALLERGY at DailyMed |
Recent Clinical Trials for CETIRIZINE HYDROCHLORIDE ALLERGY
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Phayao | NA |
| Pengfei Qiu | NA |
| Shandong New Time Pharmaceutical Co., LTD | PHASE3 |
Pharmacology for CETIRIZINE HYDROCHLORIDE ALLERGY
| Drug Class | Histamine-1 Receptor Antagonist |
| Mechanism of Action | Histamine H1 Receptor Antagonists |
US Patents and Regulatory Information for CETIRIZINE HYDROCHLORIDE ALLERGY
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm Inds Ltd | CETIRIZINE HYDROCHLORIDE ALLERGY | cetirizine hydrochloride | TABLET;ORAL | 077498-001 | Dec 27, 2007 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Orbion Pharms | CETIRIZINE HYDROCHLORIDE ALLERGY | cetirizine hydrochloride | TABLET;ORAL | 078862-002 | Feb 19, 2009 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Unique | CETIRIZINE HYDROCHLORIDE ALLERGY | cetirizine hydrochloride | TABLET;ORAL | 077829-001 | Aug 26, 2009 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Torrent Pharms Llc | CETIRIZINE HYDROCHLORIDE ALLERGY | cetirizine hydrochloride | TABLET;ORAL | 079191-001 | Apr 15, 2010 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
